ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Tonix Pharmaceuticals Holding Corporation

Tonix Pharmaceuticals Holding Corporation (TNXP)

30,51
7,48
(32,48%)
Beim Schlusskurs: 24 März 9:00PM
29,5015
-1,01
( -3,31% )
Nach Börsenschluss: 10:40PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
29,5015
Gebot
29,50
Fragen
29,66
Volumen
7.396.477
26,55 Tagesbereich 37,83
6,76 52-Wochen-Bereich 1.146,0064
Marktkapitalisierung
Handelsende
23,03
Handelsbeginn
28,90
Letzte Trade
15
@
29.6
Letzter Handelszeitpunkt
22:40:33
Finanzvolumen
US$ 229.231.667
VWAP
30,992
Durchschnittliches Volumen (3 Mio.)
48.435.370
Ausgegebene Aktien
5.590.445
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,46
Gewinn pro Aktie (EPS)
-20,87
Erlöse
7,77M
Nettogewinn
-116,66M

Über Tonix Pharmaceuticals Holding Corporation

Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio is composed of immunology, rare disease, infectious dise... Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio is composed of immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. Tonix's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500 which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Tonix's rare disease portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Carson City, Nevada, USA
Gegründet
-
Tonix Pharmaceuticals Holding Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNXP. The last closing price for Tonix Pharmaceuticals was US$23,03. Over the last year, Tonix Pharmaceuticals shares have traded in a share price range of US$ 6,76 to US$ 1.146,0064.

Tonix Pharmaceuticals currently has 5.590.445 shares in issue. The market capitalisation of Tonix Pharmaceuticals is US$128,75 million. Tonix Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.46.

TNXP Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
114.201592.820261437915.330.615.03202549420.01088973CS
420.3015220.6684782619.230.66.76191768115.16247335CS
12-4.6685-13.662569505434.1758.36.764843537031.87354753CS
2615.8015115.33941605813.71306.767203627034.74356621CS
52-1077.6985-97.33548591041107.21146.00646.764192649243.72781406CS
156-4828.4985-99.39272334294858958006.76170371513358.58409704CS
260-16770.4985-99.824395833316800958006.76174094899127.81225062CS

TNXP - Frequently Asked Questions (FAQ)

What is the current Tonix Pharmaceuticals share price?
The current share price of Tonix Pharmaceuticals is US$ 29,5015
How many Tonix Pharmaceuticals shares are in issue?
Tonix Pharmaceuticals has 5.590.445 shares in issue
What is the market cap of Tonix Pharmaceuticals?
The market capitalisation of Tonix Pharmaceuticals is USD 128,75M
What is the 1 year trading range for Tonix Pharmaceuticals share price?
Tonix Pharmaceuticals has traded in the range of US$ 6,76 to US$ 1.146,0064 during the past year
What is the PE ratio of Tonix Pharmaceuticals?
The price to earnings ratio of Tonix Pharmaceuticals is -1,46
What is the cash to sales ratio of Tonix Pharmaceuticals?
The cash to sales ratio of Tonix Pharmaceuticals is 21,95
What is the reporting currency for Tonix Pharmaceuticals?
Tonix Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Tonix Pharmaceuticals?
The latest annual turnover of Tonix Pharmaceuticals is USD 7,77M
What is the latest annual profit for Tonix Pharmaceuticals?
The latest annual profit of Tonix Pharmaceuticals is USD -116,66M
What is the registered address of Tonix Pharmaceuticals?
The registered address for Tonix Pharmaceuticals is 769 BASQUE WAY, SUITE 300, CARSON CITY, NEVADA, 89706
What is the Tonix Pharmaceuticals website address?
The website address for Tonix Pharmaceuticals is www.tonixpharma.com
Which industry sector does Tonix Pharmaceuticals operate in?
Tonix Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TNONTenon Medical Inc
US$ 1,49
(52,34%)
10,54M
TROOTROOPS Inc
US$ 1,10
(30,95%)
669,03k
STFSStar Fashion Culture Holdings Ltd
US$ 1,4001
(30,17%)
1,39M
LVLULulus Fashion Lounge Holdings Inc
US$ 0,50
(15,96%)
12,57k
CREVCarbon Revolution Public Ltd
US$ 3,47
(15,28%)
423
TRSGTungray Technologies Inc
US$ 1,53
(-25,37%)
1,48M
IMTEIntergrated Media Technology Ltd
US$ 1,61
(-23,33%)
3,02M
ATOMAtomera Incorporated
US$ 4,52
(-21,66%)
128,95k
PROPPrairie Operating Company
US$ 4,70
(-19,80%)
81,86k
CAPSCapstone Holding Corp
US$ 2,40
(-13,36%)
70,29k
DGLYDigital Ally Inc
US$ 0,0481
(-12,23%)
10,87M
TNONTenon Medical Inc
US$ 1,49
(52,34%)
10,54M
MLGOMicroAlgo Inc
US$ 12,91
(-7,72%)
7,75M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 11,47
(2,78%)
5,72M
HOLOMicroCloud Hologram Inc
US$ 1,11
(0,00%)
5,58M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock